Global Animal Vaccines Market Insights Forecasts to 2033.

• The Global Animal Vaccines Market Size was Valued at USD 13.6 Billion in 2023
• The Market Size is Growing at a CAGR of 6.67% from 2023 to 2033
• The Worldwide Animal Vaccines Market Size is Expected to Reach USD 26.1 Billion by 2033
• Asia Pacific Market is expected to grow the fastest during the forecast period.

The Global Animal Vaccines Market Size is anticipated to exceed USD 26.1 Billion by 2033, Growing at a CAGR of 6.67% from 2023 to 2033.

Market Overview

Animal vaccines are crucial veterinary medicine for preventing and controlling infectious diseases in various species. Similar to human vaccines, they stimulate an immune response in animals, protecting them against specific pathogens such as viruses, bacteria, and parasites. These vaccines play a vital role in maintaining animal health, enhancing food safety, and preventing the transmission of diseases from animals to humans. They are used on a wide range of animals, including livestock such as cattle, pigs, and poultry, as well as pets like dogs and cats. By reducing disease incidence and promoting overall well-being, animal vaccines contribute significantly to sustainable agriculture, animal welfare, and public health efforts worldwide. Inactivated vaccines, live attenuated vaccines, subunit vaccines, and some other vaccines are the most widely used in animals. Animal vaccines play a crucial role in preventing and controlling diseases among livestock, which significantly impacts productivity and profitability in the agricultural sector. Vaccines help to protect animals from various infectious diseases, thereby reducing the risk of illness, mortality, and economic losses for farmers. The global animal vaccine market is driven by increased awareness about animal health worldwide.

Report Coverage

This research report categorizes the market for the global animal vaccines market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global animal vaccines market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global animal vaccines market.

Driving Factors

The global animal vaccine market is driven by various factors, including the increased prevalence of zoonotic diseases. The demand for animal vaccines is projected to rise as zoonotic disease prevalence rises and its detrimental effects on human health become more apparent. Food security is at risk due to newly discovered and exotic animal diseases, which pose an increasing hazard to both human and animal health. Increased chances for pathogen transmission within and across species result from growing human and animal populations, environmental deterioration, globalized trade, and increased travel. According to the Centre for Disease Control and Prevention, 6 out of 10 diseases are spread by animals. The ensuing illnesses present enormous concerns both now and in the future. A greater demand for animal protein has led to a rise in the production of commercial food animals throughout most of the world. Public health is seriously threatened by newly emerging zoonotic diseases in both companion and farmed animals. In addition, increased animal husbandry and growing worries about food security are driving up demand for animal vaccines among livestock owners. Global livestock output has increased as a result of rising consumer demand for animal products. The demand for animal products is also rising as a result of a number of causes, including population growth and changes in dietary choices brought on by changing lifestyles.

Restraining Factors

Vaccines for veterinary animals have a number of side effects. Local side effects include soreness and localized swelling at the vaccination site, reduced energy and appetite, a low-grade temperature, sneezing, runny nose, and light coughing. This hinders the expansion of the global animal vaccines market.

Market Segmentation

The Global Animal Vaccines Market share is classified into product type, animal type, and route of administration.

• The attenuated live vaccines segment is expected to hold the largest share of the global animal vaccines market during the forecast period.   

Based on the product type, the global animal vaccines market is divided into attenuated live vaccines, recombinant vaccines, and others. Among these, the attenuated live vaccines segment is expected to hold the largest share of the global animal vaccines market during the forecast period. The most traditional immunization technique in the veterinary industry is live attenuation. Trials of this approach are also being conducted in order to develop other applications. A couple of these options include the development of intramuscular protein subunit vaccinations for pigs. These products help swine that are afflicted with diseases live longer and experience lower death rates.

• The livestock segment is expected to grow at the fastest pace in the global animal vaccines market during the forecast period.    

Based on the animal type, the global animal vaccines market is divided into livestock, companion, and others. Among these, the livestock segment is expected to grow at the fastest pace in the global animal vaccines market during the forecast period. The increasing number of livestock, encouraging government programs, and the emergence of diseases in sheep and cattle are some of the causes of this. Merck & Co., Inc. has produced two vaccines called Aviguard and Nobilis E. coli inac, which are intended to prevent E. coli. The incidence percentage of E. Coli varies from 0.2% to 27.8% in different cow groups (feedlot animals, cattle on irrigated pasture, cattle at slaughter, and cattle on rangeland forages), according to Zoetis.

• The subcutaneous segment is expected to hold the largest share of the global animal vaccines market during the forecast period.   

Based on the route of administration, the global animal vaccines market is divided into oral, subcutaneous, intramuscular, intranasal, and others. Among these, the subcutaneous segment is expected to hold the largest share of the global animal vaccines market during the forecast period. Most animals have subcutaneous injection sites in their necks and behind their shoulder blades. The ability of medications to be injected subcutaneously and absorbed gradually by the body is anticipated to propel market expansion. For animals, the subcutaneous approach also causes less discomfort. Moreover, subcutaneous injection training for veterinary professionals is less complicated. The most popular methods of administration for animals nowadays are intramuscular and subcutaneous, and these factors support market expansion.   

Regional Segment Analysis of the Global Animal Vaccines Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global animal vaccines market over the predicted timeframe.

North America is anticipated to hold the largest share of the global animal vaccines market over the predicted timeframe. This large share is attributed to the high prevalence of livestock and zoonotic diseases leading to large-scale animal deaths. In addition, the large presence of well-established pharmaceutical firms that are consistently striving for wide commercialization of their vaccines and augmenting their geographical reach is expected to boost market growth. In addition, the rising incidence of canine disorders, which is increasing the adoption of vaccinations for the same, and the rising pet population in the U.S. are some of the key factors contributing to the expansion of the regional market.

Asia-Pacific is expected to grow the fastest during the forecast period. Government efforts, particularly in developing nations, and the projected increase in the livestock population are some of the main drivers predicted to propel market expansion in the area. According to the Ministry of Fisheries, Animal Husbandry, and Dairy, India’s cattle population will reach 303.76 million in 2023. Because of this, there is a need for vaccines in a nation with such a large cow population. The market is driven by significant R&D spending by several large competitors, along with an increase in efforts to commercialize veterinary vaccinations and inoculations at reasonable costs.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global animal vaccines along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Zoetis
• Ceva Santé Animale
• Merck & Co., Inc.
• Vetoquinol S.A.
• Boehringer Ingelheim Gmbh
• Elanco
• Virbac
• Heska
• Bayer AG
• Sanofi
• Pfizer
• GSK
• Indovax
• Hester Biosciences Limited.
• Dechra Pharmaceuticals PLC
• Takeda Pharmaceutical Company Limited
• Idexx Laboratories, Inc.
• Norbrook Inc.
• Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In September 2022, Zoetis declared that the acquisition of Jurox, a privately held animal health business that creates, produces, and sells a variety of veterinary medications for the treatment of companion and livestock animals, had been completed.

• In May 2021, Boehringer Ingelheim India declared the release of VAXXITEK HVT+IBD, a vaccination for poultry. VAXXITEK HVT+IBD is a novel recombinant vaccine that is administered as a single dose to provide lifelong protection for broiler, layer, and breeder hens.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Animal Vaccines Market based on the below-mentioned segments: 

Global Animal Vaccines Market, By Product Type

• Attenuated Live Vaccines
• Recombinant Vaccines
• Others

Global Animal Vaccines Market, By Animal Type

• Livestock
• Companion
• Others.

Global Animal Vaccines Market, By Route of Administration

• Oral
• Subcutaneous
• Intramuscular
• Intranasal
• Others

Global Animal Vaccines Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa